TrialCardiovascular diabetology2024

Ipragliflozin and sitagliptin differentially affect lipid and apolipoprotein profiles in type 2 diabetes: the SUCRE study.

Mototsugu Nagao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.